Skip to main content
Caplight Logo









LifeSprout

LifeSprout

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://www.lifesproutbio.com/

Last Round

Series A

Apr 27, 2020

Total Funding Raised

$35.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

LifeSprout is a biotechnology company that develops synthetic soft tissue substitutes for use in aesthetic and reconstructive medicine to facilitate tissue regeneration and repair.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Fashion & Beauty, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

regenerative medicinedermal fillerbiomaterial technologytissue scaffoldaesthetic medicinebiotechfacial rejuvenationbio-fillermedical deviceregenerative aestheticstissue engineeringbiomimeticsclinical-stage biotechbiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LifeSprout Comparables

Compare LifeSprout with similar companies based on industry and business-model similarity.

LifeSprout comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Spiderwort
82%
Tiger Biosciences
79%
MTF Biologics
77%

LifeSprout Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 27, 2020
SeedMay 29, 2019
SeedMar 21, 2018

LifeSprout Investors

Notable investors and investment history

LifeSprout investors
InvestorRounds
Redmile GroupSeries A
Emerald Development ManagersSeries A
Abell FoundationSeries A, Seed
TEDCOSeed
Kairos VenturesSeed
AngelMDSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors increased 63% MoM, reaching 1.8K.

  • Apr 27, 2020

    $29M round led by Redmile Group.

LifeSprout Filings

Explore SEC and related filing metadata, where available.

LifeSprout filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about LifeSprout's valuation, stock price, and market status.

Is LifeSprout a public or private company?

LifeSprout is a private company.

What is the current stock price of LifeSprout?

LifeSprout is a private company with no public stock price. No recent secondary market data is available.

How much is LifeSprout worth (valuation)?

Valuation information for LifeSprout is not publicly available.

Can I buy LifeSprout stock?

LifeSprout shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was LifeSprout's last funding round?

LifeSprout's most recent funding round was Series A on April 27, 2020.

Who are the main investors in LifeSprout?

Key investors in LifeSprout include Redmile Group, TEDCO, Kairos Ventures.

Will LifeSprout IPO soon?

No public IPO plans have been announced for LifeSprout.

How can I track LifeSprout secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LifeSprout's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range19
Year Founded2015
Last FundingApr 27, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?